Interchange Capital Partners’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$329K Sell
12,998
-5,825
-31% -$155K 0.1% 189
2025
Q4
$469K Sell
18,823
-1,383
-7% -$34.9K 0.09% 211
2025
Q3
$515K Buy
20,206
+6,095
+43% +$150K 0.1% 178
2025
Q2
$342K Buy
14,111
+280
+2% +$6.53K 0.08% 202
2025
Q1
$350K Sell
13,831
-552
-4% -$14.4K 0.1% 181
2024
Q4
$385K Sell
14,383
-5,383
-27% -$146K 0.14% 159
2024
Q3
$572K Sell
19,766
-939
-5% -$27.4K 0.2% 120
2024
Q2
$579K Buy
+20,705
New +$570K 0.21% 117
2023
Q3
Sell
-7,527
Closed -$277K 165
2023
Q2
$277K Sell
7,527
-6,566
-47% -$256K 0.21% 115
2023
Q1
$578K Buy
14,093
+9,421
+202% +$407K 0.31% 83
2022
Q4
$239K Sell
4,672
-1,375
-23% -$65.9K 0.24% 100
2022
Q3
$264K Sell
6,047
-200
-3% -$9.72K 0.29% 100
2022
Q2
$327K Sell
6,247
-268
-4% -$13.7K 0.37% 86
2022
Q1
$337K Sell
6,515
-601
-8% -$31.2K 0.35% 100
2021
Q4
$420K Buy
7,116
+2,016
+40% +$99.9K 0.42% 78
2021
Q3
$219K Sell
5,100
-875
-15% -$38.8K 0.37% 90
2021
Q2
$233K Sell
5,975
-8,555
-59% -$333K 0.36% 87
2021
Q1
$581K Sell
14,530
-3,085
-18% -$110K 0.32% 103
2020
Q4
$648K Buy
+17,615
New +$646K 0.35% 77

Other funds holding PFE

Interchange Capital Partners's PFE Position: Q1 2026 in Review

Interchange Capital Partners reduced its Pfizer (PFE) stake by 31% in Q1 2026, selling an estimated $155K and leaving 12,998 shares worth $329K. The position accounts for 0.1% of the portfolio, ranked #189.

Interchange Capital Partners first reported a position in PFE in Q4 2020 and has held it in 19 quarters since. The position peaked at $648K in Q4 2020. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Interchange Capital Partners held 12,998 shares of Pfizer worth $329K as of Q1 2026.
  • Interchange Capital Partners sold 5,825 Pfizer shares in Q1 2026, an estimated $155K.
  • Pfizer made up 0.1% of Interchange Capital Partners's portfolio in Q1 2026, its #189 holding.
  • Interchange Capital Partners first reported a position in Pfizer in Q4 2020 and has held it in 19 quarters since.
  • Interchange Capital Partners's Pfizer position peaked at $648K in Q4 2020.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Interchange Capital Partners's 13F filing for Q1 2026, filed 24 Apr 2026.